awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38371860-66D2AA9B-D343-41F0-9AF2-6993768E4235
Q38371860-66D2AA9B-D343-41F0-9AF2-6993768E4235
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38371860-66D2AA9B-D343-41F0-9AF2-6993768E4235
Transforming Concepts Into Clinical Trials and Creating a Multisite Network: The Leadership and Operations Center of the Antibacterial Resistance Leadership Group.
P2860
Q38371860-66D2AA9B-D343-41F0-9AF2-6993768E4235
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38371860-66D2AA9B-D343-41F0-9AF2-6993768E4235
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
09d8c798dd75111946540939743fd924283c395f
P2860
Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial.